View all results
No results
News
Events
The industry
Industry overview
Industrial biotech
Swiss Biotech Report
Success Stories
Company directory
Jobs
Talent platform
Networking platforms
Newsletter
Association
Our mission
Members
Academy
Insight Events
Partners
Team
Media
Add listing
Log in
or
Register
0
Add listing
ND017
Product
prev
next
Leave a review
Claim listing
Bookmark
Share
Report
prev
next
Therapeutic indications
Metabolic disorder
Company
Numab Therapeutics AG
You may also be interested in
OligoPhore / SemaPhore Peptide-Based RNA Delivery Platforms
Delivers siRNA, antisense oligonucleotides, mRNA and other mRNA modalities to extrahepatic tissues - demonstrated across various indications in oncology (e.g. PDAC, breast cancer, ovarian cancer, lung cancer, melanoma, ATLL, TME), and inflammatory / autoimmune diseases (e.g. OA, RA, enterocolitis), CV (e.g. atherosclerosis, aortic aneurysm)
Featured
Discovery
Sublingual semaglutide
obesity and diabetes
Discovery
A2AR positive allosteric modulator
Multiple, see therapeutic areas. GI indications also relevant.
Discovery
Cart
×
View all results
No results
Facebook
X
WhatsApp
Telegram
Pinterest
LinkedIn
Tumblr
Reddit
VKontakte
Mail
Copy link
Share via...
This site uses cookies:
Find out more.
Accept